The VC Market Balances: AI Loses Dominance as Capital Flows to Biotech, Quantum, and Deep Tech

For the first time in months, artificial intelligence accounted for less than half of all venture capital deployed in a single week. Between June 14–20, VCs distributed funding across 96 startups and growth rounds, and while AI companies claimed $7.4 billion—nearly half the deployed capital—the other 51 deals ($10.2 billion) painted a more encouraging picture for investors seeking diversification beyond the crowded AI market.

The numbers matter less than what they reveal: VC money is finally balancing.

When One Deal Reshapes the Entire Week

DeepSeek's Series A funding round—$7.4 billion led by Tencent, with CATL and other investors joining—dominated the week's headlines and skewed the aggregate AI percentage upward. But peel back the hype, and this outlier actually reinforces the main story: even with a generational mega-round, non-AI startups captured 53% of all deals by count, and competitive returns are appearing outside the AI bubble.

Excluding the DeepSeek round, AI companies raised approximately $2.8 billion across 45 separate deals—a still-significant figure, but one that suggests the market is rebalancing rather than abandoning core technology investment.

Biotech and Quantum Emerge as the New Frontiers

While founders pitching "generative AI applications" faced increasing skepticism, companies tackling gene editing, quantum computing, and semiconductor design found eager investors. Scribe Therapeutics closed $25+ million for CRISPR-based gene editing programs, Connie Health raised $40 million (including an acquisition of Clearlink's Medicare business), and Atom Computing secured $100 million in Series C funding for quantum computing infrastructure.

This isn't coincidence. After a decade of cloud computing commoditization and two years of AI hype, VCs are rotating capital toward hardware, biotech, and quantum—verticals that demand longer R&D timelines but promise structurally defensible moats once they scale.

The quantum computing sector alone saw $100+ million deployed in a single week. OQC's expansion into Southern Europe signals that quantum isn't a Silicon Valley phenomenon anymore; investors are backing geographic diversity in compute infrastructure.

Deep Tech Gets Real: Semiconductors and Energy Infrastructure

Architect Labs, a stealth startup making custom silicon accessible to smaller design teams, emerged with $24 million in funding. Specx raised $2.2 million for hyperspectral imaging technology aimed at space applications. Meanwhile, Solar Foods closed a €77.8 million package for cultivated protein technology, backed by a €500 million EU dual-use defense fund.

These deals share a DNA: they're capital-intensive, require deep technical expertise, and solve industrial problems rather than consumer conveniences. The market is finally rewarding founders who build the infrastructure and materials the AI industry depends on, rather than just another ChatGPT wrapper.

Geography Signals a Maturing Global Market

DeepSeek aside, the week's funding distribution reveals a geographic rebalancing. European founders raised capital for quantum centers (Barcelona), semiconductor tools (Copenhagen-adjacent fintech), and sustainable agriculture. Indian startups (aggregated in a $426 million weekly roundup) captured meaningful investor attention. The US, while still the largest market, no longer monopolizes VC momentum.

This matters for founders: access to capital is no longer Silicon Valley-centric. A hardware startup with strong engineering in Munich, a biotech play in London, or a quantum team in Barcelona can now attract tier-one investors without relocating.

Why This Matters

The VC market's reset—from "all-in on AI" to "AI plus everything else"—suggests several things: First, LPs are pushing back against concentration risk. Second, founders outside AI are finally receiving signals that patient capital exists for long-duration research. Third, the era of "spray and pray" AI company creation is ending; capital efficiency is returning as a metric.

If this pattern holds through Q3, expect more cycles into quantum, biotech, and infrastructure. The winners won't be companies that claim "we use AI," but those that build irreplaceable capabilities the AI industry—and the broader economy—depend on.